Isilon Rolls Out Unified Scale-Out Storage Platform



By Bio-IT World Staff

September 1, 2010
| Data storage company Isilon is introducing what it claims is the industry’s first and only unified scale-out storage platform for the enterprise, by integrating the iSCSI protocol into its OneFS operating system.

The new platform allows clients to consolidate file- and block-based applications onto a single, shared pool of storage, simplifying data management to increase resource utilization and efficiency for virtualized and non-virtualized environments.   

Sam Grocott, Isilon’s VP marketing, told Bio-IT World that historically, Isilon focused on NAS (network-attached storage) for unstructured data. “Last year, we introduced products to focus on segment of virtualized data, so we could handle virtualized and file data. Now, we’re introducing a unified scale platform.”
 
“We’re the only enterprise vendor offering file and block,” adds Nick Kirsch, director of product development.
 
“Until now, enterprises have been forced to either deploy separate systems for separate applications, or attempt to consolidate on complex architectures that handicap growth and inflate costs,” says Grocott. Isilon’s latest storage solutions “meet the needs of today’s virtualized enterprise data center by scaling storage in-line with virtual server demands to minimize costs and maximize efficiency.” 

“Applications like vmware and email require block storage requiring iSCSI [a protocol for accessing a block device], whereas bioinformatics and sequencing are file-based applications,” says Grocott. With the addition of block to file, all can now be stored in the unified scale-out system. “It’s no longer just your file or sequenced data,” says Grocott. One current life sciences customer is the Oklahoma Medical Research Research, which has consolidated all its life sciences data into one storage pool.

Growth Curve
By delivering both file- and block-level data access from a single, scale-out solution, Isilon says it can eliminate the data fragmentation common with traditional SAN and NAS in virtualized environments.
 
“Bioinformatics groups don’t [typically] have an army of IT managers,” says Grocott. “They’re not only managing sequencing storage but databases, analysis, etc. . . Now they can simplify their environment even more, consolidate SAN and block-storage applications into the same single resource, which is easy to manage and grow. It’s a major advance in consolidating and simplifying these environments that aren’t IT centric.”

And one more thing, says Grocott: “It is free and seamless,” at least to existing customers.

Isilon is one of several storage companies enjoying a purple patch as the demand for storage in life sciences and other verticals surges. Business grew nearly 50% in the first half of 2010, with 17% revenues attributable to the life sciences sector, Isilon’s second largest vertical after media. The firm’s stock price reflects that growth, rising about 350% in the past 12 months.

Among Isilon’s marquee customers in the life sciences space are the Broad Institute and BGI (formerly the Beijing Genomics Institute), which Grocott says has been a customer since the beginning of 2010. Grocott won’t divulge precise numbers but says that Isilon is “working very closely to help with the build out” of BGI’s data center, which could reach a staggering one Exabyte by the end of this year.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .